Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Lakshmi

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Cardiovascular Diabetology|January 28, 2014
CNX-012-570, a direct AMPK activator provides strong glycemic and lipid control along with significant reduction in body weight; studies from both diet-induced obese mice and db/db mice modelsTharappel M Anil, Chandrashekaran Harish, Mudigere N Lakshmi, et al.
BMC Pharmacology & Toxicology|August 8, 2014
A novel 11β-hydroxysteroid dehydrogenase type1 inhibitor CNX-010-49 improves hyperglycemia, lipid profile and reduces body weight in diet induced obese C57B6/J mice with a potential to provide cardio protective benefitsTharappel M Anil, Anilkumar Dandu, KrishnaReddy Harsha, et al.
Diabetology & Metabolic Syndrome|August 22, 2014
CNX-013-B2, a unique pan tissue acting rexinoid, modulates several nuclear receptors and controls multiple risk factors of the metabolic syndrome without risk of hypertriglyceridemia, hepatomegaly and body weight gain in animal modelsManoj Kumar Sadasivuni, Bobbili Madhusudhan Reddy, Jaideep Singh, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Cardiovascular Diabetology|January 28, 2014
CNX-012-570, a direct AMPK activator provides strong glycemic and lipid control along with significant reduction in body weight; studies from both diet-induced obese mice and db/db mice modelsTharappel M Anil, Chandrashekaran Harish, Mudigere N Lakshmi, et al.
BMC Pharmacology & Toxicology|August 8, 2014
A novel 11β-hydroxysteroid dehydrogenase type1 inhibitor CNX-010-49 improves hyperglycemia, lipid profile and reduces body weight in diet induced obese C57B6/J mice with a potential to provide cardio protective benefitsTharappel M Anil, Anilkumar Dandu, KrishnaReddy Harsha, et al.
Diabetology & Metabolic Syndrome|August 22, 2014
CNX-013-B2, a unique pan tissue acting rexinoid, modulates several nuclear receptors and controls multiple risk factors of the metabolic syndrome without risk of hypertriglyceridemia, hepatomegaly and body weight gain in animal modelsManoj Kumar Sadasivuni, Bobbili Madhusudhan Reddy, Jaideep Singh, et al.
Pageof 6